# US 2015/0031600 A1 · Designed biosurfactants, their manufacture, purification and use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0031600 A1
- Document ID: US20150031600A1
- Status: Published application
- Kind: A1
- Application number: 13/994,482
- Filed: 2011-12-14
- Published: 2015-01-29
- Earliest claimed: 2010-12-14
- Assignees: The University of Queensland
- Inventors: Anton Peter Jacob Middelberg; Mirjana Dimitrijev-Dwyer; Michael Brech
- Web page: https://patentgrep.com/patent/US20150031600A1

## CPC

- C11D 3/386: Preparations containing enzymes {, e.g. protease or amylase}
- C07K 14/00: Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K 14/001: {by chemical synthesis}
- C11D 3/3719: {Polyamides or polyimides}
- C11D 3/38: Products with no well-defined composition {, e.g. natural products}
- C11D: DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention relates to designed polypeptide biosurfactants that may be prepared by recombinant technology in commercially useful amounts and purified by simple non-chromatographic methods. The designed polypeptide biosurfactants comprise at least one stimuli-responsive amino acid residue or at least one glutamine or asparagine residue and may be useful in modulating the stability of a foam, alone or in combination with an α-helical peptide. The designed polypeptide biosurfactant may be useful in the formation and collapse of foams in foods, beverages, pharmaceuticals, personal care products, cosmetics, cleaning products, mineral recovery, bioremediation, oil recovery and laundry products. The designed biosurfactants may also be useful in recombinant production and purification of peptides, polypeptides and proteins.

## Claims

### Claim at position 1

1-75. (canceled)

### Claim 76

A polypeptide or protein comprising at least two α-helical peptides linked by a linking sequence of 3 to 11 amino acid residues, wherein the protein or polypeptide has a folded tertiary structure with a hydrophobic core and a hydrophilic surface; and
wherein each α-helical peptide comprises a sequence of amino acid residues:
(a b c d d′ e f g)n
wherein n is an integer from 2 to 12;
amino acid residues a and d are hydrophobic amino acid residues;
amino acid residue d′ is absent or is a hydrophobic amino acid residue;
at least one of amino acid residues b and c and at least one of amino acid residues e and f are hydrophilic amino acid residues, the other of amino acid residues b and c and e and f are any amino acid residue, provided that amino acid residues b and c are not both charged amino acid residues with the same charge and amino acid residues e and f are not both charged amino acid residues with the same charge;
amino acid residue g is any amino acid residue;
wherein
i) each α-helical peptide comprises at least one stimuli-responsive amino acid residue; or
ii) each sequence (a b c d d′ e f g) in the α-helical peptide comprises at least one glutamine or asparagine residue and no net charge or each sequence (a b c d d′ e f g) comprises at least one glutamine or asparagine residue and one negative charge.

### Claim 77 (depends on 76)

The polypeptide or protein according to claim 76 wherein the at least one stimuli-responsive amino acid residue is a lysine residue.

### Claim 78 (depends on 76)

The polypeptide or protein according to claim 76 wherein the at least one stimuli-responsive amino acid residue is a histidine residue.

### Claim 79 (depends on 76)

The polypeptide or protein according to claim 76 wherein the at least one stimuli-responsive amino acid residue results from each sequence (a b c d d′ e f g) in the α-helical peptide having a net negative or positive charge.

### Claim 80 (depends on 76)

The polypeptide or protein according to claim 76 wherein each sequence (a b c d d′ e f g) in the α-helical peptide comprises at least two glutamine or asparagine residues and no net charge.

### Claim 81 (depends on 76)

The polypeptide or protein according to claim 76 wherein each sequence (a b c d d′ e f g) in the α-helical peptide comprises at least one glutamine or asparagine residues and one negative charge.

### Claim 82 (depends on 76)

The polypeptide or protein according to claim 76 wherein the linking sequence has 3 to 5 amino acid residues.

### Claim 83 (depends on 82)

The polypeptide or protein according to claim 82 wherein the linking sequence has 3 amino acid residues.

### Claim 84 (depends on 76)

The polypeptide or protein according to claim 76 wherein the linking sequence comprises a cleavable bond.

### Claim 85 (depends on 84)

The polypeptide or protein according to claim 84 wherein the cleavable bond is an acid cleavable bond.

### Claim 86 (depends on 85)

The polypeptide or protein according to claim 85 wherein the acid cleavable bond is a D-P bond.

### Claim 87 (depends on 85)

The polypeptide or protein according to claim 85 wherein the linking sequence comprises the sequence D-P-S.

### Claim 88 (depends on 87)

The polypeptide or protein according to claim 87 wherein the linking sequence is D-P-S.

### Claim 89

A method of modulating the stability of foam comprising a protein or polypeptide biosurfactant at a liquid-gas interface; wherein said biosurfactant comprises at least two α-helical peptides linked by a linking sequence of 3 to 11 amino acid residues, and wherein each α-helical peptide comprises a sequence of amino acid residues:
(a b c d d′ e f g)n
wherein n is an integer from 2 to 12;
amino acid residues a and d are hydrophobic amino acid residues;
amino acid residue d′ is absent or is a hydrophobic amino acid residue;
at least one of amino acid residues b and c and at least one of amino acid residues e and f are hydrophilic amino acid residues, the other of amino acid residues b and c and e and f are any amino acid residue, provided that amino acid residues b and c are not both charged amino acid residues with the same charge and amino acid residues e and f are not both charged amino acid residues with the same charge;
amino acid residue g is any amino acid residue;
and wherein each α-helical peptide comprises a stimuli-responsive amino acid residue;
said method comprising the step of:
i) exposing the biosurfactant to a stimulus that alters the zeta potential and/or surface charge of the biosurfactant at the liquid-gas interface or the metal ion binding of the biosurfactant or hydration structure of the biosurfactant at the liquid-gas interface.

### Claim 90 (depends on 89)

The method according to claim 89 wherein the α-helical peptide of the protein or polypeptide biosurfactant comprises at least one lysine residue.

### Claim 91 (depends on 89)

The method according to claim 89 wherein the stimulus that alters the zeta potential and surface charge of the biosurfactant at the liquid-gas interface alters the pH of the foam.

### Claim 92 (depends on 89)

The method according to claim 89 wherein the stimulus is an acid or a base.

### Claim 93 (depends on 89)

The method according to claim 89 wherein the pH is altered by dilution of bulk aqueous phase from which the foam is formed.

### Claim 94 (depends on 89)

The method according to claim 89 wherein the α-helical peptide of the protein or polypeptide biosurfactant comprises at least one histidine residue.

### Claim 95 (depends on 89)

The method according to claim 89 wherein the stimulus alters the metal ion binding of the biosurfactant.

### Claim 96 (depends on 95)

The method according to claim 95 wherein the stimulus is a metal ion or a chelating agent.

### Claim 97 (depends on 89)

The method according to claim 89 wherein each sequence (a b c d d′ e f g) in the α-helical peptide of the protein or polypeptide biosurfactant has a net negative or positive charge at a specified pH or has no net charge at a specified pH.

### Claim 98 (depends on 97)

The method according to claim 97 wherein the stimulus alters the hydration structure of the biosurfactant at the liquid-gas interface.

### Claim 99 (depends on 98)

The method according to claim 98 wherein the stimulus is a kosmotropic or chaotropic salt.

### Claim 100 (depends on 89)

The method according to claim 89 wherein the stimulus stabilizes or maintains the foam.

### Claim 101 (depends on 89)

The method according to claim 89 wherein the stimulus destabilizes the foam or causes it to collapse.

### Claim 102 (depends on 89)

The method according to claim 89 further comprising the step of:
ii) exposing the biosurfactant to a second stimulus that alters the zeta potential and/or surface charge of the biosurfactant at the liquid-gas interface or the metal ion binding of the biosurfactant or hydration structure of the biosurfactant at the liquid-gas interface adopted on exposure to the stimulus in step i).

### Claim 103 (depends on 102)

The method according to claim 102 wherein steps i) and/or ii) are repeated one or more times.

### Claim 104 (depends on 1, 89)

The method according to claim 89 wherein the foam further comprises an a-helical peptide comprising the amino acid sequence:
X1-(a b c d d′ e f g)n-X2
wherein n is an integer from 2 to 12;
amino acid residues a and d are hydrophobic amino acid residues;
amino acid residue d′ is absent or is a hydrophobic amino acid residue;
at least one of amino acid residues b and c and at least one of amino acid residues e and f are hydrophilic amino acid residues, the other of amino acid residues b and c and e and f are any amino acid residue, provided that amino acid residues b and c are not both charged amino acid residues with the same charge and amino acid residues e and f are not both charged amino acid residues with the same charge;
amino acid residue g is any amino acid residue;
X1 and X2 are each independently absent or are amino acid residues from a cleavable linking sequence of the polypeptide or protein of claim 1 and wherein the number of amino acid residues in X1 and X2 is 3 to 11 amino acid residues and wherein at least one amino acid residue is a stimuli-responsive amino acid residue.

### Claim 105 (depends on 104)

The method according to claim 104 wherein the at least one stimuli-responsive amino acid residue is a lysine residue.

### Claim 106 (depends on 104)

The method according to claim 104 wherein the at least one stimuli-responsive amino acid residue is a histidine residue.

### Claim 107 (depends on 104)

The method according to claim 104 wherein the at least one stimuli-responsive amino acid residue results from each sequence (a b c d d′ e f g) in the a-helical peptide having a net negative or positive charge.

### Claim 108 (depends on 104)

The method according to claim 104 wherein each sequence (a b c d d′ e f g) in the α-helical peptide comprises at least two glutamine or asparagine residues and no net charge.

### Claim 109 (depends on 104)

The method according to claim 104 wherein each sequence (a b c d d′ e f g) in the α-helical peptide comprises at least one glutamine or asparagine residues and one negative charge.

### Claim 110 (depends on 104)

The method according to claim 104 wherein X1 comprises a proline residue and X2 comprises an aspartyl residue.

### Claim 111 (depends on 110)

The method according to claim 110 wherein X1 comprises the sequence P-S and X2 comprises an aspartyl residue.

### Claim 112 (depends on 111)

The method according to claim 111 wherein X1 is P-S and X2 is D.

### Claim 113 (depends on 89)

The method according to claim 89 wherein the foam further comprises an antimicrobial peptide.

### Claim 114

The method of modulating the stability of a foam comprising the steps of:
i) forming a stable foam from a foaming composition; said foaming composition comprising:
a. a first bulk aqueous phase having a pH of 8.3 or above;
b. a biosurfactant having at least two α-helical peptides linked by a linking sequence of 3 to 11 amino acid residues, wherein each α-helical peptide comprises a sequence of amino acid residues:
(a b c d d′ e f g)n
wherein n is an integer from 2 to 12;
amino acid residues a and d are hydrophobic amino acid residues;
amino acid residue d′ is absent or is a hydrophobic amino acid residue;
at least one of amino acid residues b and c and at least one of amino acid residues e and f are hydrophilic amino acid residues, the other of amino acid residues b and c and e and f are any amino acid residue, provided that amino acid residues b and c are not both charged amino acid residues with the same charge and amino acid residues e and f are not both charged amino acid residues with the same charge;
amino acid residue g is any amino acid residue;
wherein each α-helical peptide comprises a lysine residue;
ii) removing a substantial fraction of the first bulk aqueous phase from the foaming composition; and
iii) replacing the first bulk aqueous phase with a second bulk aqueous phase having a pH below 8.

### Claim 115 (depends on 114)

The method according to claim 114 wherein the first bulk aqueous phase has a pH of about 8.3 to 9.0.

### Claim 116 (depends on 114)

The method according to claim 114 wherein the second bulk aqueous phase has a pH of about 7.0 to 7.7.

### Claim 117 (depends on 114)

The method according to claim 114 wherein the foam composition further comprises an α-helical peptide, wherein said α-helical peptide comprises a lysine residue.

### Claim 118 (depends on 114)

The method according to claim 114 wherein the foam composition further comprises an antimicrobial peptide or a protease, amylase, lipase or cellulase enzyme.

### Claim 119

A method of purifying a polypeptide or protein biosurfactant that has a folded tertiary structure with a hydrophobic core and a hydrophilic surface; said method comprising the steps of:
i) treating a composition comprising the polypeptide or protein and other cell based protein, polypeptide and/or peptide contaminants with a kosmotropic salt in an amount suitable to salt-out the contaminants to form a precipitate and to salt-in the polypeptide or protein in solution, wherein the treatment is at a temperature of above 45° C.; and
ii) separating the precipitate from the solution containing the polypeptide or protein.

### Claim 120 (depends on 119)

The method according to claim 119 wherein step i) is performed at atmospheric pressure and a temperature above 60° C.

### Claim 121 (depends on 120)

The method according to claim 120 wherein step i) is performed at a temperature in the range of 85° C. to 100° C.

### Claim 122 (depends on 119)

The method according to claim 119 wherein the kosmotropic salt is a sulphate.

### Claim 123 (depends on 122)

The method according to claim 122 wherein the kosmotropic salt is ammonium sulphate or sodium sulphate.

### Claim 124 (depends on 122)

The method according to claim 122 wherein the amount of kosmotropic salt is in the range of 0.2 M to 1.5 M.

### Claim 125 (depends on 119)

The method according to claim 119 wherein the folded tertiary structure is a four helix bundle.

### Claim 126

A method of manufacturing a polypeptide or protein that has a folded tertiary structure with a substantially hydrophobic core and a substantially hydrophilic surface; said method comprising:
i) providing a microorganism containing a polynucleotide sequence, wherein the polynucleotide sequence comprises a nucleotide sequence that encodes the polypeptide or protein, and wherein the nucleotide sequence is operably linked to a promoter sequence;
ii) culturing the microorganism to express the polypeptide or protein;
iii) disrupting the microorganism cells to form a cell disruptate composition;
iv) treating the disruptate with a kosmotropic salt in an amount suitable to salt-out cell based protein, polypeptide and peptide contaminants to form a precipitate and salt-in the polypeptide or protein in solution, wherein the treatment is at a temperature of above 45° C.; and
v) separating the precipitate from the solution of polypeptide or protein.

### Claim 127 (depends on 126)

The method according to claim 126 wherein steps iii) and iv) are performed concurrently at atmospheric pressure and a temperature of at least 60° C.

### Claim 128 (depends on 127)

The method according to claim 127 wherein the temperature is in the range of 85° C. to 100° C.

### Claim 129 (depends on 126)

The method according to claim 126 wherein the kosmotropic salt is a sulphate.

### Claim 130 (depends on 129)

The method according to claim 129 wherein the kosmotropic salt is ammonium sulphate or sodium sulphate.

### Claim 131 (depends on 130)

The method according to claim 130 wherein the amount of kosmotropic salt is in the range of 0.2 M to 1.5M.

### Claim 132 (depends on 126)

The method according to claim 126 wherein the folded tertiary structure is a four helix bundle.

### Claim 133

A method of purifying a polypeptide or protein that has a folded α-helical tertiary structure with a substantially hydrophilic surface; the method comprising the step of:
i) treating a composition comprising microorganism cells containing the polypeptide or protein with a kosmotropic salt at a temperature of at least 45° C.

### Claim 134 (depends on 133)

A method according to claim 133 wherein step i) is performed at atmospheric pressure and a temperature of at least 60° C.

### Claim 135 (depends on 134)

The method according to claim 134 wherein the temperature is in the range of 85° C. to 100° C.

### Claim 136 (depends on 135)

A method according to claim 135 wherein step i) is performed by autoclaving.

### Claim 137 (depends on 133)

The method according to claim 133 wherein the kosmotropic salt is a sulphate.

### Claim 138 (depends on 137)

The method according to claim 137 wherein the sulphate is ammonium or sodium sulphate.

### Claim 139 (depends on 133)

The method according to claim 133 wherein the amount of kosmotropic salt is in the range of 0.2 M to 1.5 M.

### Claim 140 (depends on 133)

The method according to claim 133 wherein the folded α-helical tertiary structure is a four helix bundle.

### Claim 141 (depends on 126)

The method according to claim 126 wherein the polypeptide or protein comprises at least two α-helical peptides linked by a linking sequence of 3 to 11 amino acid residues, wherein each α-helical peptide comprises a sequence of amino acid residues:
(a b c d d′ e f g)n
wherein n is an integer from 2 to 12;
amino acid residues a and d are hydrophobic amino acid residues;
amino acid residue d′ is absent or is a hydrophobic amino acid residue;
at least one of amino acid residues b and c and at least one of amino acid residues e and f are hydrophilic amino acid residues, the other of amino acid residues b and c and e and f are any amino acid residue, provided that amino acid residues b and c are not both charged amino acid residues with the same charge and amino acid residues e and f are not both charged amino acid residues with the same charge;
amino acid residue g is any amino acid residue.

### Claim 142 (depends on 141)

The method according to claim 141 wherein the linking sequence comprises a cleavable bond and the method further comprises the step of cleaving the cleavable bond.

### Claim 143 (depends on 141)

The method according to claim 141 wherein each sequence (a b c d d′ e f g) in the α-helical peptide comprises at least one glutamine or asparagine residue and no net charge or each sequence (a b c d d′ e f g) comprises at least one glutamine or asparagine residue and one negative charge and the method further comprises the step of deamidating the glutamine and/or asparagine residues.

### Claim 144 (depends on 126)

The method according to claim 126 wherein the polynucleotide sequence further encodes a second protein, polypeptide or peptide and a cleavable linker operably linked with the nucleotide sequence encoding the polypeptide or protein, such that step ii) expresses a fusion protein comprising the second protein, polypeptide or peptide cleavably linked to the polypeptide or protein.

### Claim 145 (depends on 144)

The method according to claim 144 further comprising the step of cleaving the cleavable linker.

### Claim 146 (depends on 144)

The method according to claim 144 wherein the second protein, polypeptide or peptide is an antimicrobial peptide or a protease, lipase, amylase or cellulase enzyme or a peptide for use in the manufacture of metallic or semiconductor nanostructures.

### Claim 147 (depends on 144)

The method according to claim 144 wherein the cleavable linker between the polypeptide or protein and the second protein, polypeptide or peptide is cleaved by an enzyme at a faster rate than the rate of non-specific cleavage of the protein or polypeptide.

### Claim 148 (depends on 1, 76)

A composition comprising a polypeptide or protein according to claim 76 and an α-helical peptide comprising the amino acid sequence:
X1-(a b c d d′ e f g)n-X2
wherein n is an integer from 2 to 12;
amino acid residues a and d are hydrophobic amino acid residues;
amino acid residue d′ is absent or is a hydrophobic amino acid residue;
at least one of amino acid residues b and c and at least one of amino acid residues e and f are hydrophilic amino acid residues, the other of amino acid residues b and c and e and f are any amino acid residue, provided that amino acid residues b and c are not both charged amino acid residues with the same charge and amino acid residues e and f are not both charged amino acid residues with the same charge;
amino acid residue g is any amino acid residue;
wherein:
i) each α-helical peptide comprises at least one stimuli-responsive amino acid residue; or
ii) each sequence (a b c d d′ e f g) in the α-helical peptide comprises at least one glutamine or asparagine residue and no net charge or each sequence (a b c d d′ e f g) comprises at least one glutamine or asparagine residue and one negative charge;
X1 and X2 are each independently absent or are amino acid residues from a cleavable linking sequence of the polypeptide or protein of claim 1 and wherein the number of amino acid residues in X1 and X2 is 3 to 11 amino acid residues.

### Claim 149 (depends on 148)

A composition according to claim 148 wherein the polypeptide is a polypeptide of SEQ ID NO:1.

### Claim 150 (depends on 148)

A composition according to claim 148 wherein the α-helical peptide is a peptide of SEQ ID NO:12.
